Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.

Ítems similars

• Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
  per: North, T W, et al.
  Publicat: (1978)
• Evaluation of prodrugs of 9-beta-D-arabinofuranosyladenine for therapeutic efficacy in the topical treatment of genital herpesvirus infections in guinea pigs.
  per: Shannon, W M, et al.
  Publicat: (1983)
• Determination of Plaque Inhibitory Activity of Adenine Arabinoside (9-β-d-Arabinofuranosyladenine) for Herpesviruses Using an Adenosine Deaminase Inhibitor
  per: Bryson, Yvonne, et al.
  Publicat: (1974)
• Comparative effects of the 5'-triphosphates of 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl)adenine and 9-beta-D-arabinofuranosyladenine on DNA polymerases from L1210 leukemia cells.
  per: Allaudeen, H S, et al.
  Publicat: (1982)
• The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation
  per: Kayhan, Nalan, et al.
  Publicat: (2008)